Cargando…
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment
The FcγRII (CD32) ligands are IgFc fragments and pentraxins. The existence of additional ligands is unknown. We engineered T cells with human chimeric receptors resulting from the fusion between CD32 extracellular portion and transmembrane CD8α linked to CD28/ζ chain intracellular moiety (CD32-CR)....
Autores principales: | Sconocchia, Giuseppe, Lanzilli, Giulia, Cesarini, Valeriana, Silvestris, Domenico A, Rezvani, Katayoun, Arriga, Roberto, Caratelli, Sara, Chen, Ken, Dou, Jinzhuang, Cenciarelli, Carlo, Toietta, Gabriele, Baldari, Silvia, Sconocchia, Tommaso, De Paolis, Francesca, Aureli, Anna, Iezzi, Giandomenica, Irno Consalvo, Maria, Buccisano, Francesco, del Principe, Maria I, Maurillo, Luca, Venditti, Adriano, Ottaviani, Alessio, Spagnoli, Giulio C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586128/ https://www.ncbi.nlm.nih.gov/pubmed/36241426 http://dx.doi.org/10.26508/lsa.202201590 |
Ejemplares similares
-
FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance
por: Caratelli, Sara, et al.
Publicado: (2017) -
Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage
por: Arriga, Roberto, et al.
Publicado: (2015) -
NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma
por: Coppola, Andrea, et al.
Publicado: (2015) -
P16. Differential susceptibility of human and mouse NK cells to malignant cell-induced abnormalities in autologous combinations: a potential mechanism for the NK cell-based immunotherapy efficacy
por: Sconocchia, G, et al.
Publicado: (2014) -
Acute Lymphoblastic Leukemia Immunotherapy Treatment: Now, Next, and Beyond
por: Aureli, Anna, et al.
Publicado: (2023)